SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in YARW — Yarrow Bioscience, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in YARW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,440
+$42,886 QoQ
Shares Held
2,379
+105.8% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 44 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in YARW Over Time
Shares Held
Position Value (USD)
Derivatives in YARW
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
48,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. YARW ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in YARW
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,440 | 118,957 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $34,554 | 57,784 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $58,197 | 100,341 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $19,350 | 57,763 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $95,393 | 57,814 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $91,263 | 57,762 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $237,286 | 70,832 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $113,469 | 60,356 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $118,836 | 60,323 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $185,191 | 60,323 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $140,552 | 60,323 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $306,113 | 75,771 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $313,158 | 76,380 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $55,476 | 18,012 | Shares | Defined | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||